Basepaws
Latest round
- Seed
Last raised
- Jan 2020
Total raised
- Undisclosed
Investors
- 1
About Basepaws
a. Basepaws operates as a pet genetics company that focuses on providing pet owners with genetic tests, analytics, and early health risk assessments. In June 2022, Zoetis Inc agreed to acquire Basepaws, Inc. The company provides DNA testing for dogs, providing comprehensive insights into the pet's health and breed composition. The breed and health dog DNA test includes analysis of over 280 genetic health markers, a detailed breed breakdown, and information on more than 30 genetic traits. Basepaws also offers breed and health cat DNA tests, oral health tests for cats, and whole genome tests to empower pet owners to make informed health decisions, enhancing the care and well-being of their dogs and cats.
Who invested in Basepaws
1 investor across 1 round
See all investors in Basepaws
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 5, 2020
Amount
Undisclosed
Investors
Questions about Basepaws
Who invested in Basepaws?
Basepaws has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Basepaws raised?
Basepaws has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Basepaws last raise money?
Basepaws's most recent round on record is a Seed, in Jan 2020.
What does Basepaws do?
Basepaws is a healthcare company.
Where is Basepaws headquartered?
Basepaws is headquartered in Torrance, US.
Which VCs invest in companies like Basepaws?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Basepaws's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Basepaws? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.